General Information of the Compound
| Compound ID |
CP0379479
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
(S)-1-((4R,7S,10S,13S,16S)-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-(4-hydroxybenzyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-carbonyl)-N-((R)-1-(2-amino-2-oxoethylamino)-5-guanidino-1-oxopentan-2-yl)pyrrolidine-2-carboxamide
Show/Hide
|
||||||||||||||||||
| Synonyms |
Desmopressin Melt
1-Desamino-8-D-arginine vasopressin
Adiuretin
Adiuretin SD
DDAVP
DESMOPRESSIN
Ddavp
Deamino Arginine Vasopressin
Deamino-8-D-arginine, l-, vasopressin
Desamino-8-D-arginine vasopressin, l-
Desmopresina [INN-Spanish]
Desmopressin
Desmopressin (fast-dissolving, nocturia/diabetes insipidus)
Desmopressin (fast-dissolving, nocturia/diabetes insipidus), Ferring Pharmaceuticals
Desmopressin [INN:BAN]
Desmopressine [INN-French]
Desmopressinum
Desmopressinum [INN-Latin]
EINECS 240-726-7
FE-992026
Minirin
Minrin Melt
Noctiva
Vasopressin, 1-(3-mercaptopropanoic acid)-8-D-arginine-
Vasopressin, Deamino Arginine
[deamino-Cys1]AVP
[deamino1]AVP
dAVP
deamino-vasopressin
desnopressin
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C46H64N14O12S2
|
||||||||||||||||||
| Molecular Weight |
1069.238
|
||||||||||||||||||
| Canonical SMILES |
NC(=O)CC[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@H](NC(=O)[C@H](CC(N)=O)NC1=O)C(=O)N1CCC[C@H]1C(=O)N[C@H](CCCN=C(N)N)C(=O)NCC(N)=O
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C46H64N14O12S2/c47-35(62)15-14-29-40(67)58-32(22-36(48)63)43(70)59-33(45(72)60-18-5-9-34(60)44(71)56-28(8-4-17-52-46(50)51)39(66)53-23-37(49)64)24-74-73-19-16-38(65)54-30(21-26-10-12-27(61)13-11-26)41(68)57-31(42(69)55-29)20-25-6-2-1-3-7-25/h1-3,6-7,10-13,28-34,61H,4-5,8-9,14-24H2,(H2,47,62)(H2,48,63)(H2,49,64)(H,53,66)(H,54,65)(H,55,69)(H,56,71)(H,57,68)(H,58,67)(H,59,70)(H4,50,51,52)/t28-,29+,30+,31+,32+,33+,34+/m1/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
NFLWUMRGJYTJIN-PNIOQBSNSA-N
|
||||||||||||||||||
| CAS |
16679-58-6
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
| DrugBank ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01658, Oxytocin receptor
Protein ID: PT01839, Vasopressin V1a receptor
Protein ID: PT01840, Vasopressin V1b receptor
Protein ID: PT01884, Vasopressin V2 receptor
Protein ID: PT01648, Vasopressin V2 receptor
Clinical Information about the Compound